ToDAY® (cephapirin sodium)
A recent study presented at the 2008 National Mastitis Council found that ToDAY® (cephapirin sodium) provided a high bacteriological cure rate at the labeled dose for gram-positive infections in just one day of treatment.1
ToDAY and ToMORROW® (cephapirin benzathine) are broad-spectrum antibiotics with excellent efficacy against gram-positive pathogens.
Labeled to control penicillin-resistant Staph. aureus.
OPTI-SERT® tip aids in partial insertion.
84% bacteriologic cure rate of gram-positive pathogens for clinical quarters.1
82% bacteriologic cure rate of gram-positive pathogens for subclinical quarters.1
Milk that has been taken from animals during treatment and for 96 hours after the last treatment must not be used for food
Treated animals must not be slaughtered for food until 4 days after the last treatment.
ToDAY® Product Label
1 Apparao M.D., Ruegg P.L., Hulland C., Lago A., Godden S. Bey R., Leslie K. Relationship between MIC of Gram-positive mastitis pathogens and bacteriological outcomes following intramammary treatment with Cephapirin. 47th Annual Meeting of the National Mastitis Council; 2008 Jan. 20-23; New Orleans, Louisiana.
